Physician profile
Rick Gaines
NPI 1437544400
$3,739.56
in general payments reported to CMS, 2019-2025
22 companies · $522 in 2025
The $522 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,055 · 2022: $1,126 · 2023: $640 · 2024: $396 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,558.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,390.44 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Novartis Pharmaceuticals Corporation | $605.08 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $241.45 | 2022-2025 | Wainua |
| Pfizer INC. | $233.66 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $221.46 | 2021-2024 | Xarelto |
| Amgen INC. | $152.44 | 2021-2025 | Repatha |
| Edwards Lifesciences Corporation | $151.11 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $145.68 | 2021-2025 | Jardiance |
| Boston Scientific Corporation | $143.94 | 2022 | |
| Heartflow, INC. | $124.22 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $96.29 | 2021-2022 | |
| Irhythm Technologies, INC. | $44.79 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Cardiva Medical, INC. | $32.44 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Merck Sharp & Dohme LLC | $24.68 | 2022 | |
| Daiichi Sankyo INC. | $19.54 | 2025 | Injectafer |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $19.03 | 2022 | |
| Lantheus Medical Imaging, INC. | $18.35 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.25 | 2024 | Lifevest |
| Esperion Therapeutics, INC. | $17.49 | 2023 | Nexletol |
| Kiniksa Pharmaceuticals International, Plc | $14.35 | 2024 | Arcalyst |
| Inspire Medical Systems, INC. | $13.50 | 2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $11.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rick Gaines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.